Neuroscience

Neurologist explains how new migraine drug works

The FDA announced approval on May 17 of a novel preventive treatment for migraine headaches. Aimovig is the first in a new class of migraine-specific drugs that works by blocking an action of a protein that is increased in ...

Diseases, Conditions, Syndromes

FDA approves first drug aimed at preventing migraines

(HealthDay)—The millions of Americans who suffer from migraine may have a new source of hope—the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday.

Diseases, Conditions, Syndromes

Fremanezumab linked to fewer monthly migraine days

(HealthDay)—For patients with episodic migraine, fremanezumab is associated with a reduction in the mean number of monthly migraine days, according to a study published in the May 15 issue of the Journal of the American ...

Diseases, Conditions, Syndromes

The cold truth about migraine headaches

(HealthDay)—Early humans' ability to adapt to cold climates may have been helped by a genetic variant that's common in modern people who live in colder regions—and is linked with migraine headaches, researchers say.

Diseases, Conditions, Syndromes

86 million workdays lost to migraine in the UK every year

The equivalent of 86 million workdays are lost to migraine each year and close to £1 billion is spent on healthcare costs associated with the condition. It affects more than 23 per cent of adults with almost 200,000 attacks ...

Neuroscience

When others fail, new migraine treatment may work

People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a drug called erenumab, according to a preliminary study released today that will be presented at the American Academy of ...

page 25 from 40